To Name :
To Email :
From Name :
From Email :
Comments :

Clinical Reviews

PROM dilemmas: Choosing a strategy, knowing when to call it quits

Gestational age and fetal status determine whether expectant management or prompt delivery is best

August 2007 · Vol. 19, No. 08


CASE: PROM at 22 weeks

J.S. is a 22-year-old woman at 22 weeks’ gestation in her second pregnancy. Her first gestation ended in spontaneous abortion at 10 weeks, followed by dilation and curettage. She has been referred to you by her midwife, who is concerned about J.S.’s complaints of loss of fluid over the past 2 weeks and who cannot document rupture of membranes by the usual means.

In your office, J.S. continues to complain of intermittent leakage of clear fluid. She says there has been no vaginal bleeding, foul-smelling discharge, fever, chills, or abdominal tenderness. You find a normal abdomen. A sterile speculum exam is equivocal, without evidence of pooling or ferning; a nitrazine test is positive, however. A complete blood count reveals no evidence of leukocytosis. Urinalysis is negative.

You suspect preterm premature rupture of membranes (PROM) when bedside ultrasonography (US) documents oligohydramnios with an amniotic fluid index of less than 5 cm. The kidneys, bladder, and stomach all appear normal.

What is the best way to confirm the diagnosis? What is the most appropriate management at this gestational age? And how do you counsel J.S. about the risk to her, and her baby, of continuing the pregnancy?

Given the very poor prognosis of many cases of early PROM, accurate diagnosis is critical to determine the best management strategy. The gold standard of diagnosis is sterile vaginal examination with a speculum to identify clear fluid leaking from the cervix or pooling in the posterior fornix. Use nitrazine paper to assess the fluid collected from the posterior fornix for alkaline pH; this method has a positive predictive value (PPV) of 99% and negative predictive value (NPV) of 96%.1 The appearance of “ferning”—a crystalline pattern that occurs when the saline amniotic fluid dries—carries a PPV of 98% to 99% and a NPV of 90% to 99%.2

One must also consider the patient’s history. When that history and the physical exam fail to render a clear result, use US to assess the amniotic fluid volume. A low volume in the presence of a convincing clinical history is very suspicious for PROM, as in the case just described.

Tinting the amniotic fluid may help

In equivocal cases, mix 1 to 3 mL of indigo carmine with 5 mL of sterile saline and insert it into the amniotic fluid under US guidance. This dye will make any leaking amniotic fluid obvious. Be aware, however, that instillation of the dye is very difficult in cases of severe oligohydramnios or anhydramnios. In this setting, amniocentesis can also cause contractions or vaginal bleeding.

New diagnostic tool on the horizon

Recent studies have focused on a new rapid test (AmniSure) that uses immunochromatography to detect trace amounts of placental α-microglobulin-1 protein.3 This protein is specific to amniotic fluid and present in vaginal secretions only when amniotic fluid is leaking through the cervix. One study of 203 patients suspected of having ruptured membranes found the AmniSure test to have a PPV of 100% and NPV of 99.1%.3 Although these findings are promising, further confirmatory studies are needed before this product can be recommended for widespread use.

CASE continued: Leakage of tinted fluid confirms PROM

Because the diagnostic steps taken so far have been inconclusive, J.S. undergoes amniocentesis with infusion of indigo carmine. Within 2 hours, blue dye is observed leaking from the cervix, confirming PROM. A sample of amniotic fluid obtained at the time of amniocentesis produces a negative gram stain and reveals a normal glucose level and leukocyte count. Amniotic fluid cultures are pending.

What is your next step?

Determining the best management strategy is next. The treatment plan should be based on gestational age, presence or absence of infection or labor, and fetal status. Therefore, the initial evaluation of a patient with PROM should focus on the collection of this clinical information.

I recommend these measures:

  • Document the exact gestational age by careful review of available records and ultrasound biometry
  • Identify indicators of infection, such as maternal fever and tachycardia, fundal tenderness, fetal tachycardia, and an elevated white blood cell count
  • Amniocentesis may be required to rule out amnionitis in cases where the diagnosis is clinically unclear
  • Document fetal presentation
  • Initiate fetal heart rate (FHR) monitoring at the time of diagnosis and perform a biophysical profile (BPP).

Midtrimester PROM: 16 to 24 weeks’ gestation

Management differs for each gestational age.

Midtrimester PROM occurs in approximately 0.7% of all pregnancies and is a significant source of morbidity and mortality.4,5 It may be iatrogenic in nature when it follows an invasive procedure such as amniocentesis or fetoscopy. It also may occur spontaneously, with causes similar to those of PROM at later gestational ages. At this early gestational age, PROM is more likely to be associated with cervical incompetence and inflammation.6,7

Infection is a risk—and may be the underlying cause

Infection is associated with as many as 30% to 50% of cases of PROM.4,8-10 Half of the cases of intra-amniotic infection develop within 7 days after PROM. That’s because many cases of early PROM have infection or inflammation as their cause.

Intrauterine demise is common at early gestational ages

The risk of intrauterine fetal demise is inversely related to gestational age at the time of rupture. That is, the earlier the gestational age, the higher the rate of fetal death. One study found that the rate of intrauterine fetal demise was 33% when PROM occurred before 20 weeks’ gestation and 20% when it occurred between 20 and 24 weeks; it was rare after 25 weeks.10

Pulmonary hypoplasia is more common at this critical juncture

The midtrimester is a critical time for fetal lung development. During the canalicular stage (between 17 and 24 weeks’ gestation), the gas-exchanging acini and pulmonary capillaries are forming, so they are more susceptible to injury. The incidence of pulmonary hypoplasia is approximately 10% when PROM occurs earlier than 20 weeks’ gestation, although a wide range of rates has been reported.4,8-10 Pulmonary hypoplasia remains a significant cause of neonatal mortality and is found in as many as 77% of autopsies of infants from pregnancies complicated by midtrimester PROM.11

The incidence of pulmonary hypoplasia decreases by as much as 46% with each week of gestational age at the time of PROM.12 After 26 weeks, when the terminal sac stage of development occurs, the rate of pulmonary hypoplasia complicating PROM drops to less than 2%.12-14

The degree of oligohydramnios also affects the rate of pulmonary hypoplasia, which increases significantly when the amniotic fluid index is less than 5 cm.15

Limb deformity may be related to restricted movement

Although limb development occurs in the embryonic period, most limb growth takes place during the second and third trimesters.16 The restriction in movement and increased pressure associated with prolonged periods of oligohydramnios can lead to skeletal deformity in otherwise normal extremities.

The frequency of deformity varies widely among studies, but the mean incidence is 7%.4,8-11 A twofold higher incidence of skeletal abnormality occurs when midtrimester PROM is accompanied by severe oligohydramnios. In one study, the rate of skeletal abnormality was 54% when the deepest pocket of amniotic fluid was less than 1 cm, compared with 26% for matched pregnancies with a normal or mildly reduced volume.16

Maternal complications include retained placenta, endometritis

Maternal complications associated with very early PROM include a higher rate of cesarean section due to fetal malpresentation and FHR abnormalities, which often accompany oligohydramnios and intraamniotic infection.10 A classical incision is more likely in these cases due to the poorly developed lower uterine segment. Retained placenta necessitating postpartum curettage occurs in 9% to 18% of cases of PROM at less than 20 weeks’ gestation. In addition, postpartum endometritis complicates as many as 40% of cases of midtrimester PROM.4,8-11

General prognosis

The outcome of midtrimester PROM depends on the underlying cause. If it is iatrogenic, the outcome is usually favorable, with frequent resealing of the membranes; most cases end in a normal term delivery. The outcome of spontaneous PROM is more grim.

Midtrimester PROM has the same relatively short latency (approximately 17 days on average) as PROM that occurs later in pregnancy. Less than 50% of women with midtrimester PROM remain pregnant at the end of the first week, and as many as 75% of these women will have delivered by 28 days after PROM.11 These percentages indicate that most women with midtrimester PROM deliver before fetal viability can be attained, or in the risky periviable period.

Overall, midtrimester PROM is associated with significant fetal, neonatal, and maternal morbidity. The risks must be explained to the patient along with any management plan.

Given the very poor prognosis and small chance of prolonged latency, induction of labor and pregnancy termination are reasonable options at the time of presentation. The patient needs to know that expectant management can be associated with significant long-term morbidity and a higher rate of neonatal mortality.

CASE continued: Patient is apprised of the risks

After a frank discussion of the risks involved in continuing her pregnancy, J.S. chooses expectant management. Given the early gestational age and absence of any sign of infection, she is sent home for bed rest and instructed to check her temperature twice daily. She is told to return for evaluation if fever (>100°F) or symptoms of infection develop. Because of the very early gestational age, no steroid or antibiotic will be given until 24 weeks’ gestation, when she will be admitted for inpatient care.

PROM at 24 to 32 weeks’ gestation

Selecting a management strategy for a pregnancy at this gestational age means weighing the potential morbidity and mortality of immediate delivery against the morbidity and mortality of expectant management. At this gestational age, the principal source of fetal morbidity is prematurity itself. As many as 40% of infants delivered before 26 weeks’ gestation experience some type of long-term morbidity such as intraventricular hemorrhage (IVH), retinopathy of prematurity, necrotizing enterocolitis (NEC), or, most commonly, respiratory distress syndrome (RDS).16,17 It is true that fetal morbidity increases when chorioamnionitis is present, but the potential benefit of prolonging the pregnancy by 7 to 14 days is believed to outweigh the risk of infection at these gestational ages. Therefore, in the absence of contraindications, expectant management is the usual course of action.

Select patients carefully for expectant management

Consider expectant management only when fetal well-being can be documented, without evidence of infection. Abruption is a contraindication to expectant management, although the clinical nature of this diagnosis can make it difficult to identify. If abruption is diagnosed, aggressive management with labor augmentation or cesarean section and intravenous (IV) antibiotics is appropriate.

Repetitive fetal heart decelerations in the presence of active vaginal bleeding and uterine tenderness indicate placental insufficiency and are an indication for delivery.

More than 50% of patients deliver within the first week after PROM is diagnosed.18 At least 30% experience chorioamnionitis some time after the diagnosis of PROM, and 1% to 2% suffer cord prolapse.10,18,19 As many as 4% to 12% of cases of PROM will also be complicated by abruption,20,21 and a rate of intrauterine fetal demise as high as 1% has been documented.18 Therefore, if expectant management is selected, it should include close monitoring for these complications.

Hospitalization is warranted. Women who are stable and being managed expectantly should probably be hospitalized. One prospective trial comparing outcomes between women managed at home and women who were hospitalized found no significant difference in latency period or the rate of infection.22 However, the strict inclusion criteria for this study make it difficult to generalize the results. Only 18% of the 349 women screened for enrollment met these criteria.

Did you miss this content?
Defining “abnormal rise” is the elephant in the room